1305-0031: An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally inpatients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)(FIBRONEER???-ON)

Project: Research project

Project Details

Description

1305-0031: An open-label extension trial of the long-term safety and efficacy of BI 1015550 taken orally in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) (FIBRONEER???-ON)
StatusActive
Effective start/end date1/1/24 → 4/1/26

Funding

  • BOEHRINGER-INGELHEIM PHARMACEUTICALS

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint